The global market for NGS Sequencers was valued at US$ 1163 million in the year 2024 and is projected to reach a revised size of US$ 3243 million by 2031, growing at a CAGR of 16.0% during the forecast period.

NGS Sequencers Market

NGS sequencer is a massively parallel sequencing technology that can perform sequencing with ultra-high throughput, ultra-strong scalability, and ultra-fast speed. This technique is used to determine the order of nucleotides throughout the genome or in targeted regions of DNA or RNA.

North American market for NGS Sequencers is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for NGS Sequencers is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of NGS Sequencers include Illumina Inc., BioMérieux, Life Technologies Corporation, Thermo Fisher Scientific, Memorial Sloan Kettering, BGI, PacBio, Agilent Technologies, Gene, Roche, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for NGS Sequencers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding NGS Sequencers.

The NGS Sequencers market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global NGS Sequencers market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the NGS Sequencers manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of NGS Sequencers Market Report

Report Metric	Details
Report Name	NGS Sequencers Market
Accounted market size in year	US$ 1163 million
Forecasted market size in 2031	US$ 3243 million
CAGR	16.0%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Reversible End Termination Sequencing Semiconductor Sequencing Combined Probe Anchored Polymerization Sequencing
Segment by Application	Hospitals and Clinics Academic and Research Institutions Pharmaceutical and Biotech Companies Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Illumina Inc., BioMérieux, Life Technologies Corporation, Thermo Fisher Scientific, Memorial Sloan Kettering, BGI, PacBio, Agilent Technologies, Gene, Roche, Beckman Coulter, PerkinElmer, GTH.O, Boao Bio Group, Oxford Nanopore Technologies
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of NGS Sequencers manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of NGS Sequencers in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is NGS Sequencers Market growing?

Ans: The NGS Sequencers Market witnessing a CAGR of 16.0% during the forecast period 2025-2031.

What is the NGS Sequencers Market size in 2031?

Ans: The NGS Sequencers Market size in 2031 will be US$ 3243 million.

Who are the main players in the NGS Sequencers Market report?

Ans: The main players in the NGS Sequencers Market are Illumina Inc., BioMérieux, Life Technologies Corporation, Thermo Fisher Scientific, Memorial Sloan Kettering, BGI, PacBio, Agilent Technologies, Gene, Roche, Beckman Coulter, PerkinElmer, GTH.O, Boao Bio Group, Oxford Nanopore Technologies

What are the Application segmentation covered in the NGS Sequencers Market report?

Ans: The Applications covered in the NGS Sequencers Market report are Hospitals and Clinics, Academic and Research Institutions, Pharmaceutical and Biotech Companies, Other

What are the Type segmentation covered in the NGS Sequencers Market report?

Ans: The Types covered in the NGS Sequencers Market report are Reversible End Termination Sequencing, Semiconductor Sequencing, Combined Probe Anchored Polymerization Sequencing

1 NGS Sequencers Market Overview

1.1 Product Definition

1.2 NGS Sequencers by Type

1.2.1 Global NGS Sequencers Market Value Comparison by Type (2024 VS 2031)

1.2.2 Reversible End Termination Sequencing

1.2.3 Semiconductor Sequencing

1.2.4 Combined Probe Anchored Polymerization Sequencing

1.3 NGS Sequencers by Application

1.3.1 Global NGS Sequencers Market Value by Application (2024 VS 2031)

1.3.2 Hospitals and Clinics

1.3.3 Academic and Research Institutions

1.3.4 Pharmaceutical and Biotech Companies

1.3.5 Other

1.4 Global NGS Sequencers Market Size Estimates and Forecasts

1.4.1 Global NGS Sequencers Revenue 2020-2031

1.4.2 Global NGS Sequencers Sales 2020-2031

1.4.3 Global NGS Sequencers Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 NGS Sequencers Market Competition by Manufacturers

2.1 Global NGS Sequencers Sales Market Share by Manufacturers (2020-2025)

2.2 Global NGS Sequencers Revenue Market Share by Manufacturers (2020-2025)

2.3 Global NGS Sequencers Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of NGS Sequencers, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of NGS Sequencers, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of NGS Sequencers, Product Type & Application

2.7 Global Key Manufacturers of NGS Sequencers, Date of Enter into This Industry

2.8 Global NGS Sequencers Market Competitive Situation and Trends

2.8.1 Global NGS Sequencers Market Concentration Rate

2.8.2 The Global 5 and 10 Largest NGS Sequencers Players Market Share by Revenue

2.8.3 Global NGS Sequencers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global NGS Sequencers Market Scenario by Region

3.1 Global NGS Sequencers Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global NGS Sequencers Sales by Region: 2020-2031

3.2.1 Global NGS Sequencers Sales by Region: 2020-2025

3.2.2 Global NGS Sequencers Sales by Region: 2026-2031

3.3 Global NGS Sequencers Revenue by Region: 2020-2031

3.3.1 Global NGS Sequencers Revenue by Region: 2020-2025

3.3.2 Global NGS Sequencers Revenue by Region: 2026-2031

3.4 North America NGS Sequencers Market Facts & Figures by Country

3.4.1 North America NGS Sequencers Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America NGS Sequencers Sales by Country (2020-2031)

3.4.3 North America NGS Sequencers Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe NGS Sequencers Market Facts & Figures by Country

3.5.1 Europe NGS Sequencers Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe NGS Sequencers Sales by Country (2020-2031)

3.5.3 Europe NGS Sequencers Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific NGS Sequencers Market Facts & Figures by Region

3.6.1 Asia Pacific NGS Sequencers Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific NGS Sequencers Sales by Region (2020-2031)

3.6.3 Asia Pacific NGS Sequencers Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America NGS Sequencers Market Facts & Figures by Country

3.7.1 Latin America NGS Sequencers Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America NGS Sequencers Sales by Country (2020-2031)

3.7.3 Latin America NGS Sequencers Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa NGS Sequencers Market Facts & Figures by Country

3.8.1 Middle East and Africa NGS Sequencers Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa NGS Sequencers Sales by Country (2020-2031)

3.8.3 Middle East and Africa NGS Sequencers Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global NGS Sequencers Sales by Type (2020-2031)

4.1.1 Global NGS Sequencers Sales by Type (2020-2025)

4.1.2 Global NGS Sequencers Sales by Type (2026-2031)

4.1.3 Global NGS Sequencers Sales Market Share by Type (2020-2031)

4.2 Global NGS Sequencers Revenue by Type (2020-2031)

4.2.1 Global NGS Sequencers Revenue by Type (2020-2025)

4.2.2 Global NGS Sequencers Revenue by Type (2026-2031)

4.2.3 Global NGS Sequencers Revenue Market Share by Type (2020-2031)

4.3 Global NGS Sequencers Price by Type (2020-2031)

5 Segment by Application

5.1 Global NGS Sequencers Sales by Application (2020-2031)

5.1.1 Global NGS Sequencers Sales by Application (2020-2025)

5.1.2 Global NGS Sequencers Sales by Application (2026-2031)

5.1.3 Global NGS Sequencers Sales Market Share by Application (2020-2031)

5.2 Global NGS Sequencers Revenue by Application (2020-2031)

5.2.1 Global NGS Sequencers Revenue by Application (2020-2025)

5.2.2 Global NGS Sequencers Revenue by Application (2026-2031)

5.2.3 Global NGS Sequencers Revenue Market Share by Application (2020-2031)

5.3 Global NGS Sequencers Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Illumina Inc.

6.1.1 Illumina Inc. Company Information

6.1.2 Illumina Inc. Description and Business Overview

6.1.3 Illumina Inc. NGS Sequencers Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Illumina Inc. NGS Sequencers Product Portfolio

6.1.5 Illumina Inc. Recent Developments/Updates

6.2 BioMérieux

6.2.1 BioMérieux Company Information

6.2.2 BioMérieux Description and Business Overview

6.2.3 BioMérieux NGS Sequencers Sales, Revenue and Gross Margin (2020-2025)

6.2.4 BioMérieux NGS Sequencers Product Portfolio

6.2.5 BioMérieux Recent Developments/Updates

6.3 Life Technologies Corporation

6.3.1 Life Technologies Corporation Company Information

6.3.2 Life Technologies Corporation Description and Business Overview

6.3.3 Life Technologies Corporation NGS Sequencers Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Life Technologies Corporation NGS Sequencers Product Portfolio

6.3.5 Life Technologies Corporation Recent Developments/Updates

6.4 Thermo Fisher Scientific

6.4.1 Thermo Fisher Scientific Company Information

6.4.2 Thermo Fisher Scientific Description and Business Overview

6.4.3 Thermo Fisher Scientific NGS Sequencers Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Thermo Fisher Scientific NGS Sequencers Product Portfolio

6.4.5 Thermo Fisher Scientific Recent Developments/Updates

6.5 Memorial Sloan Kettering

6.5.1 Memorial Sloan Kettering Company Information

6.5.2 Memorial Sloan Kettering Description and Business Overview

6.5.3 Memorial Sloan Kettering NGS Sequencers Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Memorial Sloan Kettering NGS Sequencers Product Portfolio

6.5.5 Memorial Sloan Kettering Recent Developments/Updates

6.6 BGI

6.6.1 BGI Company Information

6.6.2 BGI Description and Business Overview

6.6.3 BGI NGS Sequencers Sales, Revenue and Gross Margin (2020-2025)

6.6.4 BGI NGS Sequencers Product Portfolio

6.6.5 BGI Recent Developments/Updates

6.7 PacBio

6.7.1 PacBio Company Information

6.7.2 PacBio Description and Business Overview

6.7.3 PacBio NGS Sequencers Sales, Revenue and Gross Margin (2020-2025)

6.7.4 PacBio NGS Sequencers Product Portfolio

6.7.5 PacBio Recent Developments/Updates

6.8 Agilent Technologies

6.8.1 Agilent Technologies Company Information

6.8.2 Agilent Technologies Description and Business Overview

6.8.3 Agilent Technologies NGS Sequencers Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Agilent Technologies NGS Sequencers Product Portfolio

6.8.5 Agilent Technologies Recent Developments/Updates

6.9 Gene

6.9.1 Gene Company Information

6.9.2 Gene Description and Business Overview

6.9.3 Gene NGS Sequencers Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Gene NGS Sequencers Product Portfolio

6.9.5 Gene Recent Developments/Updates

6.10 Roche

6.10.1 Roche Company Information

6.10.2 Roche Description and Business Overview

6.10.3 Roche NGS Sequencers Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Roche NGS Sequencers Product Portfolio

6.10.5 Roche Recent Developments/Updates

6.11 Beckman Coulter

6.11.1 Beckman Coulter Company Information

6.11.2 Beckman Coulter Description and Business Overview

6.11.3 Beckman Coulter NGS Sequencers Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Beckman Coulter NGS Sequencers Product Portfolio

6.11.5 Beckman Coulter Recent Developments/Updates

6.12 PerkinElmer

6.12.1 PerkinElmer Company Information

6.12.2 PerkinElmer Description and Business Overview

6.12.3 PerkinElmer NGS Sequencers Sales, Revenue and Gross Margin (2020-2025)

6.12.4 PerkinElmer NGS Sequencers Product Portfolio

6.12.5 PerkinElmer Recent Developments/Updates

6.13 GTH.O

6.13.1 GTH.O Company Information

6.13.2 GTH.O Description and Business Overview

6.13.3 GTH.O NGS Sequencers Sales, Revenue and Gross Margin (2020-2025)

6.13.4 GTH.O NGS Sequencers Product Portfolio

6.13.5 GTH.O Recent Developments/Updates

6.14 Boao Bio Group

6.14.1 Boao Bio Group Company Information

6.14.2 Boao Bio Group Description and Business Overview

6.14.3 Boao Bio Group NGS Sequencers Sales, Revenue and Gross Margin (2020-2025)

6.14.4 Boao Bio Group NGS Sequencers Product Portfolio

6.14.5 Boao Bio Group Recent Developments/Updates

6.15 Oxford Nanopore Technologies

6.15.1 Oxford Nanopore Technologies Company Information

6.15.2 Oxford Nanopore Technologies Description and Business Overview

6.15.3 Oxford Nanopore Technologies NGS Sequencers Sales, Revenue and Gross Margin (2020-2025)

6.15.4 Oxford Nanopore Technologies NGS Sequencers Product Portfolio

6.15.5 Oxford Nanopore Technologies Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 NGS Sequencers Industry Chain Analysis

7.2 NGS Sequencers Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 NGS Sequencers Production Mode & Process Analysis

7.4 NGS Sequencers Sales and Marketing

7.4.1 NGS Sequencers Sales Channels

7.4.2 NGS Sequencers Distributors

7.5 NGS Sequencers Customer Analysis

8 NGS Sequencers Market Dynamics

8.1 NGS Sequencers Industry Trends

8.2 NGS Sequencers Market Drivers

8.3 NGS Sequencers Market Challenges

8.4 NGS Sequencers Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Illumina Inc

bioMérieux

Life Technologies Corporation

Oxford Nanopore Technologies

Boao Bio Group

List of Tables

Table 1. Global NGS Sequencers Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global NGS Sequencers Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global NGS Sequencers Market Competitive Situation by Manufacturers in 2024

Table 4. Global NGS Sequencers Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global NGS Sequencers Sales Market Share by Manufacturers (2020-2025)

Table 6. Global NGS Sequencers Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global NGS Sequencers Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market NGS Sequencers Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of NGS Sequencers, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of NGS Sequencers, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of NGS Sequencers, Product Type & Application

Table 12. Global Key Manufacturers of NGS Sequencers, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global NGS Sequencers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NGS Sequencers as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global NGS Sequencers Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global NGS Sequencers Sales by Region (2020-2025) & (K Units)

Table 18. Global NGS Sequencers Sales Market Share by Region (2020-2025)

Table 19. Global NGS Sequencers Sales by Region (2026-2031) & (K Units)

Table 20. Global NGS Sequencers Sales Market Share by Region (2026-2031)

Table 21. Global NGS Sequencers Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global NGS Sequencers Revenue Market Share by Region (2020-2025)

Table 23. Global NGS Sequencers Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global NGS Sequencers Revenue Market Share by Region (2026-2031)

Table 25. North America NGS Sequencers Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America NGS Sequencers Sales by Country (2020-2025) & (K Units)

Table 27. North America NGS Sequencers Sales by Country (2026-2031) & (K Units)

Table 28. North America NGS Sequencers Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America NGS Sequencers Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe NGS Sequencers Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe NGS Sequencers Sales by Country (2020-2025) & (K Units)

Table 32. Europe NGS Sequencers Sales by Country (2026-2031) & (K Units)

Table 33. Europe NGS Sequencers Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe NGS Sequencers Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific NGS Sequencers Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific NGS Sequencers Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific NGS Sequencers Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific NGS Sequencers Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific NGS Sequencers Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America NGS Sequencers Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America NGS Sequencers Sales by Country (2020-2025) & (K Units)

Table 42. Latin America NGS Sequencers Sales by Country (2026-2031) & (K Units)

Table 43. Latin America NGS Sequencers Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America NGS Sequencers Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa NGS Sequencers Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa NGS Sequencers Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa NGS Sequencers Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa NGS Sequencers Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa NGS Sequencers Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global NGS Sequencers Sales (K Units) by Type (2020-2025)

Table 51. Global NGS Sequencers Sales (K Units) by Type (2026-2031)

Table 52. Global NGS Sequencers Sales Market Share by Type (2020-2025)

Table 53. Global NGS Sequencers Sales Market Share by Type (2026-2031)

Table 54. Global NGS Sequencers Revenue (US$ Million) by Type (2020-2025)

Table 55. Global NGS Sequencers Revenue (US$ Million) by Type (2026-2031)

Table 56. Global NGS Sequencers Revenue Market Share by Type (2020-2025)

Table 57. Global NGS Sequencers Revenue Market Share by Type (2026-2031)

Table 58. Global NGS Sequencers Price (US$/Unit) by Type (2020-2025)

Table 59. Global NGS Sequencers Price (US$/Unit) by Type (2026-2031)

Table 60. Global NGS Sequencers Sales (K Units) by Application (2020-2025)

Table 61. Global NGS Sequencers Sales (K Units) by Application (2026-2031)

Table 62. Global NGS Sequencers Sales Market Share by Application (2020-2025)

Table 63. Global NGS Sequencers Sales Market Share by Application (2026-2031)

Table 64. Global NGS Sequencers Revenue (US$ Million) by Application (2020-2025)

Table 65. Global NGS Sequencers Revenue (US$ Million) by Application (2026-2031)

Table 66. Global NGS Sequencers Revenue Market Share by Application (2020-2025)

Table 67. Global NGS Sequencers Revenue Market Share by Application (2026-2031)

Table 68. Global NGS Sequencers Price (US$/Unit) by Application (2020-2025)

Table 69. Global NGS Sequencers Price (US$/Unit) by Application (2026-2031)

Table 70. Illumina Inc. Company Information

Table 71. Illumina Inc. Description and Business Overview

Table 72. Illumina Inc. NGS Sequencers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Illumina Inc. NGS Sequencers Product

Table 74. Illumina Inc. Recent Developments/Updates

Table 75. BioMérieux Company Information

Table 76. BioMérieux Description and Business Overview

Table 77. BioMérieux NGS Sequencers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. BioMérieux NGS Sequencers Product

Table 79. BioMérieux Recent Developments/Updates

Table 80. Life Technologies Corporation Company Information

Table 81. Life Technologies Corporation Description and Business Overview

Table 82. Life Technologies Corporation NGS Sequencers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Life Technologies Corporation NGS Sequencers Product

Table 84. Life Technologies Corporation Recent Developments/Updates

Table 85. Thermo Fisher Scientific Company Information

Table 86. Thermo Fisher Scientific Description and Business Overview

Table 87. Thermo Fisher Scientific NGS Sequencers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Thermo Fisher Scientific NGS Sequencers Product

Table 89. Thermo Fisher Scientific Recent Developments/Updates

Table 90. Memorial Sloan Kettering Company Information

Table 91. Memorial Sloan Kettering Description and Business Overview

Table 92. Memorial Sloan Kettering NGS Sequencers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Memorial Sloan Kettering NGS Sequencers Product

Table 94. Memorial Sloan Kettering Recent Developments/Updates

Table 95. BGI Company Information

Table 96. BGI Description and Business Overview

Table 97. BGI NGS Sequencers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. BGI NGS Sequencers Product

Table 99. BGI Recent Developments/Updates

Table 100. PacBio Company Information

Table 101. PacBio Description and Business Overview

Table 102. PacBio NGS Sequencers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. PacBio NGS Sequencers Product

Table 104. PacBio Recent Developments/Updates

Table 105. Agilent Technologies Company Information

Table 106. Agilent Technologies Description and Business Overview

Table 107. Agilent Technologies NGS Sequencers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Agilent Technologies NGS Sequencers Product

Table 109. Agilent Technologies Recent Developments/Updates

Table 110. Gene Company Information

Table 111. Gene Description and Business Overview

Table 112. Gene NGS Sequencers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Gene NGS Sequencers Product

Table 114. Gene Recent Developments/Updates

Table 115. Roche Company Information

Table 116. Roche Description and Business Overview

Table 117. Roche NGS Sequencers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Roche NGS Sequencers Product

Table 119. Roche Recent Developments/Updates

Table 120. Beckman Coulter Company Information

Table 121. Beckman Coulter Description and Business Overview

Table 122. Beckman Coulter NGS Sequencers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. Beckman Coulter NGS Sequencers Product

Table 124. Beckman Coulter Recent Developments/Updates

Table 125. PerkinElmer Company Information

Table 126. PerkinElmer Description and Business Overview

Table 127. PerkinElmer NGS Sequencers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 128. PerkinElmer NGS Sequencers Product

Table 129. PerkinElmer Recent Developments/Updates

Table 130. GTH.O Company Information

Table 131. GTH.O Description and Business Overview

Table 132. GTH.O NGS Sequencers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 133. GTH.O NGS Sequencers Product

Table 134. GTH.O Recent Developments/Updates

Table 135. Boao Bio Group Company Information

Table 136. Boao Bio Group Description and Business Overview

Table 137. Boao Bio Group NGS Sequencers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 138. Boao Bio Group NGS Sequencers Product

Table 139. Boao Bio Group Recent Developments/Updates

Table 140. Oxford Nanopore Technologies Company Information

Table 141. Oxford Nanopore Technologies Description and Business Overview

Table 142. Oxford Nanopore Technologies NGS Sequencers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 143. Oxford Nanopore Technologies NGS Sequencers Product

Table 144. Oxford Nanopore Technologies Recent Developments/Updates

Table 145. Key Raw Materials Lists

Table 146. Raw Materials Key Suppliers Lists

Table 147. NGS Sequencers Distributors List

Table 148. NGS Sequencers Customers List

Table 149. NGS Sequencers Market Trends

Table 150. NGS Sequencers Market Drivers

Table 151. NGS Sequencers Market Challenges

Table 152. NGS Sequencers Market Restraints

Table 153. Research Programs/Design for This Report

Table 154. Key Data Information from Secondary Sources

Table 155. Key Data Information from Primary Sources

Table 156. Authors List of This Report

List of Figures

Figure 1. Product Picture of NGS Sequencers

Figure 2. Global NGS Sequencers Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global NGS Sequencers Market Share by Type: 2024 & 2031

Figure 4. Reversible End Termination Sequencing Product Picture

Figure 5. Semiconductor Sequencing Product Picture

Figure 6. Combined Probe Anchored Polymerization Sequencing Product Picture

Figure 7. Global NGS Sequencers Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global NGS Sequencers Market Share by Application: 2024 & 2031

Figure 9. Hospitals and Clinics

Figure 10. Academic and Research Institutions

Figure 11. Pharmaceutical and Biotech Companies

Figure 12. Other

Figure 13. Global NGS Sequencers Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global NGS Sequencers Market Size (2020-2031) & (US$ Million)

Figure 15. Global NGS Sequencers Sales (2020-2031) & (K Units)

Figure 16. Global NGS Sequencers Average Price (US$/Unit) & (2020-2031)

Figure 17. NGS Sequencers Report Years Considered

Figure 18. NGS Sequencers Sales Share by Manufacturers in 2024

Figure 19. Global NGS Sequencers Revenue Share by Manufacturers in 2024

Figure 20. Global 5 and 10 Largest NGS Sequencers Players: Market Share by Revenue in NGS Sequencers in 2024

Figure 21. NGS Sequencers Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 22. Global NGS Sequencers Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 23. North America NGS Sequencers Sales Market Share by Country (2020-2031)

Figure 24. North America NGS Sequencers Revenue Market Share by Country (2020-2031)

Figure 25. United States NGS Sequencers Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Canada NGS Sequencers Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Europe NGS Sequencers Sales Market Share by Country (2020-2031)

Figure 28. Europe NGS Sequencers Revenue Market Share by Country (2020-2031)

Figure 29. Germany NGS Sequencers Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. France NGS Sequencers Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. U.K. NGS Sequencers Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Italy NGS Sequencers Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Russia NGS Sequencers Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Asia Pacific NGS Sequencers Sales Market Share by Region (2020-2031)

Figure 35. Asia Pacific NGS Sequencers Revenue Market Share by Region (2020-2031)

Figure 36. China NGS Sequencers Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Japan NGS Sequencers Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. South Korea NGS Sequencers Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. India NGS Sequencers Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Australia NGS Sequencers Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. China Taiwan NGS Sequencers Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Southeast Asia NGS Sequencers Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Latin America NGS Sequencers Sales Market Share by Country (2020-2031)

Figure 44. Latin America NGS Sequencers Revenue Market Share by Country (2020-2031)

Figure 45. Mexico NGS Sequencers Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Brazil NGS Sequencers Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Argentina NGS Sequencers Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Middle East and Africa NGS Sequencers Sales Market Share by Country (2020-2031)

Figure 49. Middle East and Africa NGS Sequencers Revenue Market Share by Country (2020-2031)

Figure 50. Turkey NGS Sequencers Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia NGS Sequencers Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. UAE NGS Sequencers Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Global Sales Market Share of NGS Sequencers by Type (2020-2031)

Figure 54. Global Revenue Market Share of NGS Sequencers by Type (2020-2031)

Figure 55. Global NGS Sequencers Price (US$/Unit) by Type (2020-2031)

Figure 56. Global Sales Market Share of NGS Sequencers by Application (2020-2031)

Figure 57. Global Revenue Market Share of NGS Sequencers by Application (2020-2031)

Figure 58. Global NGS Sequencers Price (US$/Unit) by Application (2020-2031)

Figure 59. NGS Sequencers Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions